Dr. O'Regan Discusses BELLE-3 Study in Breast Cancer

Dr. O'Regan Discusses BELLE-3 Study in Breast Cancer

Other buzz videos

ER-signaling in HER2-postive Breast Cancer - Dr. Ruth O'Regan

ER-signaling in HER2-postive Breast Cancer - Dr. Ruth O'Regan

Extended Adjuvant Therapy for HER2+ Early Breast Cancer

Extended Adjuvant Therapy for HER2+ Early Breast Cancer

Immunotherapy in Breast Cancer

Immunotherapy in Breast Cancer

Crizotinib for ALK-Rearranged NSCLC

Crizotinib for ALK-Rearranged NSCLC

Understanding the Options in Multi-Gene Panels

Understanding the Options in Multi-Gene Panels

Dr. Thomas Lynch III at 9/11 Conference Panel

Dr. Thomas Lynch III at 9/11 Conference Panel

Tolerability-Guided Dose Adjustment of Afatinib in NSCLC

Tolerability-Guided Dose Adjustment of Afatinib in NSCLC

CDK4/6 Inhibitors in Hormone Receptor-Driven MBC

CDK4/6 Inhibitors in Hormone Receptor-Driven MBC

10/16/2015: "Evolution of Targeted Therapies in Breast Cancer: New Opportunities for Cure"

10/16/2015: "Evolution of Targeted Therapies in Breast Cancer: New Opportunities for Cure"

Das Traumschiff: Hochzeitsreise nach Apulien (Kreuzfahrt ins Glück)

Das Traumschiff: Hochzeitsreise nach Apulien (Kreuzfahrt ins Glück)

Dr. Lorch on the Treatment of Medullary Thyroid Cancer

Dr. Lorch on the Treatment of Medullary Thyroid Cancer

What to Do After Progression on Immunotherapy and for Non-Driver NSCLC

What to Do After Progression on Immunotherapy and for Non-Driver NSCLC

Integrating Immunotherapy into Small Cell Lung Cancer Treatment - A Review of New Data.mp4

Integrating Immunotherapy into Small Cell Lung Cancer Treatment - A Review of New Data.mp4

Dr. Bunn on Current Role of Precision Medicine for Lung Cancer

Dr. Bunn on Current Role of Precision Medicine for Lung Cancer

Sandra Swain, Washington Cancer Institute, Washington, United States

Sandra Swain, Washington Cancer Institute, Washington, United States

Dr. William Gradishar on Updates in NCCN Breast Cancer Guidelines

Dr. William Gradishar on Updates in NCCN Breast Cancer Guidelines

Dr. Herbst on the Impact of Frontline Immunotherapy in Lung Cancer

Dr. Herbst on the Impact of Frontline Immunotherapy in Lung Cancer

Cancer and Its Effects On Bones

Cancer and Its Effects On Bones

Dr. Lynch on Targeting EGFR Mutation Subtypes in Lung Cancer

Dr. Lynch on Targeting EGFR Mutation Subtypes in Lung Cancer

Adam Brufsky, MD - University of Pittsburgh Medical Center

Adam Brufsky, MD - University of Pittsburgh Medical Center